[RNA polymerase: The Achilles heel of SARS-CoV-2]

Med Sci (Paris). 2021 Mar;37(3):288-292. doi: 10.1051/medsci/2021019. Epub 2021 Mar 19.
[Article in French]
No abstract available

Publication types

  • News

MeSH terms

  • Antimetabolites / chemistry
  • Antimetabolites / therapeutic use
  • Antiviral Agents* / chemical synthesis
  • Antiviral Agents* / therapeutic use
  • COVID-19 / pathology
  • COVID-19 / virology
  • COVID-19 Drug Treatment
  • Coronavirus RNA-Dependent RNA Polymerase* / antagonists & inhibitors
  • Coronavirus RNA-Dependent RNA Polymerase* / physiology
  • Drug Discovery* / methods
  • Drug Discovery* / trends
  • Humans
  • Molecular Targeted Therapy / methods
  • Molecular Targeted Therapy / trends
  • RNA, Viral / drug effects
  • RNA, Viral / genetics
  • RNA, Viral / metabolism
  • RNA-Dependent RNA Polymerase / antagonists & inhibitors
  • RNA-Dependent RNA Polymerase / physiology
  • Ribavirin / chemistry
  • Ribavirin / therapeutic use
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / physiology*
  • Virus Replication / drug effects*
  • Virus Replication / genetics

Substances

  • Antimetabolites
  • Antiviral Agents
  • RNA, Viral
  • Ribavirin
  • Coronavirus RNA-Dependent RNA Polymerase
  • NSP12 protein, SARS-CoV-2
  • RNA-Dependent RNA Polymerase